Release Date: 19/04/22 10:56 Summary: Appointment of Peter Hatfull as a Director Price Sensitive: No Download Document 337.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%